The foundations of mammalian development lie in a cluster of embryonic epiblast stem cells. In response to extracellular matrix signalling, these cells undergo epithelialization and create an apical surface in contact with a cavity 1,2 , a fundamental event for all subsequent development. Concomitantly, epiblast cells transit through distinct pluripotent states 3, 4 , before lineage commitment at gastrulation. These pluripotent states have been characterized at the molecular level 5 , but their biological importance remains unclear. Here we show that exit from an unrestricted naive pluripotent state is required for epiblast epithelialization and generation of the pro-amniotic cavity in mouse embryos. Embryonic stem cells locked in the naive state are able to initiate polarization but fail to undergo lumenogenesis. Mechanistically, exit from naive pluripotency activates an Oct4-governed transcriptional program that results in expression of glycosylated sialomucin proteins and the vesicle tethering and fusion events of lumenogenesis. Similarly, exit of epiblasts from naive pluripotency in cultured human postimplantation embryos triggers amniotic cavity formation and developmental progression. Our results add tissue-level architecture as a new criterion for the characterization of different pluripotent states, and show the relevance of transitions between these states during development of the mammalian embryo.
, the anti-adhesive sialomucin protein podocalyxin 7 (Podxl) first became polarized apically and was then secreted when the lumen appeared (Fig. 1a) . Deep-sequencing analysis at successive implantation stages revealed the kinetics of pluripotent transitions. We found that at embryonic day (E)4.5 and E4.75 epiblasts grouped together and expressed naive pluripotency genes at similar levels, whereas gene expression in the epiblast at E5.0 was distinct and naive pluripotency genes were downregulated (although Nanog expression was already reduced at E4.5-E4.75; Table 1) . When considered together with previous datasets 8 , our findings reveal two distinct groups, namely pre-implantation (E3.5-E4.75) and postimplantation (E5.0-E5.5) epiblast populations. In the second population, naive genes were downregulated to a similar extent at E5.5 compared to E5.0, whereas post-implantation gene expression was higher at E5.5 compared to E5.0 (Extended Data Fig. 1h, i) . Therefore, the naive gene expression network is dismantled at lumenogenesis.
To determine whether there is a causal relationship between these events, we cultured E4.5 embryos in IVC1 medium 9 supplemented with 2i/LIF (consisting of a MEK inhibitor, GSK3 inhibitor and leukaemia inhibitory factor (LIF)), which maintains mouse embryonic stem (mES) cells in the naive state 10 . We found that 2i/LIF preserved expression of Nanog and inhibited Podxl expression and lumenogenesis ( Fig. 1d-f ). We confirmed that the naive state was maintained in mES cells derived from embryos cultured in IVC1 medium containing 2i/LIF (Extended Data Fig. 1j , k). Embryos in IVC1 medium containing 2i/LIF did not resume development upon 2i/LIF removal (Extended Data Fig. 1l -n), indicating that the kinetics of naive pluripotency exit are tightly coordinated with morphogenesis.
We next examined the kinetics of polarization and lumenogenesis in relation to naive pluripotency exit using mES cells cultured in Matrigel as a model system for embryogenesis 1 (Extended Data Fig. 2a ). Upon 2i/LIF removal and after the first cell division, all polarity markers that we examined exhibited polarized localization. Upon subsequent divisions, mES cells organized into polarized rosettes that opened to form lumens 36 h after 2i/LIF removal (Extended Data Fig. 2b-d ). This coincided with the loss of naive pluripotency gene expression (Extended Data Fig. 2e -l and Supplementary Videos 1-3), whereas expression of the core pluripotency markers Oct4 (also known as Pou5f1) and Sox2 was maintained. Expression of early post-implantation genes, including Otx2, was induced, but lineage priming factors were not expressed (Extended Data Fig. 2m -q) similar to the E5.5 epiblast 4, 8 . When 2i/LIF was removed before the cells were plated in Matrigel, lumens formed after 24 h without a rosette (Extended Data Fig. 3a-c) , similar to post-implantation-like primed human embryonic stem (hES) cells 11, 12 .
To address whether naive pluripotency exit is required for polarization, we cultured mES cells in Matrigel with 2i/LIF for 24-36 h (Fig. 2a) . Notably, cells displayed polarization of subcellular components despite the maintenance of Nanog levels ( Fig. 3n-p) . As expected 13 , mES cells cultured without 2i/LIF progressively lost the ability to generate colonies (Fig. 2g ). In agreement with the above results, Dgcr8 knockout mES cells, which remain in a naive state when left untreated 14 , underwent polarization. Furthermore, maintenance of naive pluripotency with a PKC inhibitor letter reSeArCH letter reSeArCH did not impair polarization (Fig. 2i , j and Extended Data Fig. 3q-v) . Therefore, mES cells can reversibly initiate polarization without losing their naive character. Next, we analysed mES cells 48 h after plating in Matrigel (Fig. 3a) . Whereas mES cells cultured without 2i/LIF formed lumens, mES cells cultured with 2i/LIF remained as closed rosettes and expressed the naive markers Nanog and Rex1 (also known as Zfp42); Oct4 was expressed at similar levels in both conditions ( Fig. 3b and Extended Data Fig.  4a-c) . Electron microscopy revealed that while mES cells formed expanded lumens in the absence of 2i/LIF, mES cells cultured with 2i/LIF displayed either no, or only rudimentary, lumens despite having apically localized tight junctions and Golgi apparatus (Extended Data Fig. 4d, e) . Over time, rosettes of mES cells in 2i/LIF lost polarization and became disorganized (Fig. 3c, d and Extended Data Fig.  4f-h) . Similar to what we observed in embryos, mES cells cultured in Matrigel with medium containing 2i/LIF did not resume morphogenesis upon 2i/LIF removal (Extended Data Fig. 4i-l) . To test whether the lumenogenesis defect was a direct consequence of pluripotency status, we cultured mES cells with a combination of two supplements (both the MEK and GSK3 inhibitors together (2i); the MEK inhibitor and LIF; and the GSK3 inhibitor and LIF) that are known to be sufficient to maintain naive pluripotency 16 . All combinations inhibited lumenogenesis and preserved Nanog expression (Extended Data Fig. 4m-o) . When given a single supplement, mES cells forming lumens showed decreased Nanog expression (Extended Data  Fig. 4p, q) . Dgcr8 knockout mES cells expressing high Nanog levels also showed a lumenogenesis defect (Fig. 3e-g and Extended Data Fig. 5a-d) . Similarly, PKC inhibition preserved Rex1 and Nanog expression, and impaired lumenogenesis (Extended Data Fig. 5e-h) . Notably, when we first induced naive pluripotency exit and then cultured cells in Matrigel with medium containing 2i/LIF, those cells that expressed Podxl, but lacked Nanog expression, formed lumens f, Lumen formation in cells from e. n = 29 (control + 2i/LIF), 31 (control − 2i/LIF), 31 (Dgcr8 knockout + 2i/LIF) and 31 (Dgcr8 knockout − 2i/LIF) spheroids. χ 2 test; NS, not significant. g, Nanog intensity in cells from e. n = 20 (control + 2i/LIF), 20 (control − 2i/LIF), 19 (Dgcr8 knockout + 2i/LIF) and 21 (Dgcr8 knockout − 2i/LIF) spheroids. Kruskal-Wallis test; * * * P < 0.0001; * P < 0.05. h, Immunostaining of control and Oct4 knockdown mES cells. Arrows indicate lumens. i, Lumen formation in cells from h. n = 39 (control), 53 (Oct4 siRNA with Oct4 (Oct4 siRNAtreated cells that did not show a reduction in Oct4 expression)) and 32 (Oct4 siRNA without Oct4 (Oct4 siRNA-treated cells that showed a reduction in Oct4 expression)) spheroids. χ test; * * * P < 0.0001. Scale bars, 10 μ m (b, c, e, h). M, Matrigel. letter reSeArCH (Extended Data Fig. 5i-m) . Next, we sought to identify the transcription factors that regulate lumenogenesis. Constitutive expression of Nanog enhances self-renewal 17 . However, we found that Nanog overexpression in the absence of 2i/LIF and serum was insufficient to block lumenogenesis and to preserve the naive network (Extended Data Fig. 5n-r) . Similarly, Nanog downregulation was insufficient to promote lumenogenesis with 2i/LIF, and Rex1 levels remained constant (Extended Data Fig. 5s-v) . We next focused on Oct4, because, together with Otx2, it drives enhancer activation upon naive pluripotency exit 18, 19 . Decreasing Oct4 expression led to defective lumenogenesis and reduced Otx2 levels (Fig. 3h, i and Extended Data Fig. 5w, x) . These results indicate that the pluripotency network directs lumen formation and epithelialization through Oct4.
For further mechanistic insights, we tested whether the fusion of apical vesicles 20 mediates lumenogenesis. Cells expressing a dominantnegative form of Rab11a (Rab11a
S25N
) 21 failed to form lumens (Fig. 4a, b) . Apical vesicles carry components involved in lumenogenesis, such as Podxl 22 . Because Podxl was not expressed in naive conditions (Fig. 1a and Extended Data Fig. 6a-d) , we evaluated its role in lumenogenesis using RNA interference. mES cells lacking Podxl showed a lumen formation defect at 48 h, without alterations in naive pluripotency exit or polarization (Extended Data Fig. 6e-k) . To determine the longterm consequences of Podxl deficiency, we generated Podxl knockout mES cells. Podxl knockout mES cells showed defective lumenogenesis after 48 h, but formed lumens by 72 h (Fig. 4c, d and Extended Data Fig. 6l-m) , in agreement with the lack of lethality of Podxl knockout embryos 23 . This lumenogenesis delay was rescued by overexpression of Cd34, which encodes a sialomucin expressed at very low levels at E5.5 8 (Extended Data Fig. 6n, p) . Moreover, treatment with protamine sulfate, which neutralises the negative charges of sialomucins 24 , blocked lumen formation at 72 h ( Fig. 4e-f ), indicating that sialomucins mediate lumenogenesis via cell repulsion. Next, we analysed whether Podxl expression was regulated by Oct4-Otx2. We found that Otx2 knockout mES cells expressed low levels of Podxl and displayed a lumenogenesis delay (Extended Data Fig. 7a-d) , which was rescued by Otx2 overexpression using a doxycycline (DOX)-inducible system (Extended Data  Fig. 7e, f) . In agreement with previous results 6, 18 , Otx2 overexpression in the presence of 2i/LIF was able to induce naive pluripotency exit in 50% of wild-type and 35% of Otx2-knockout mES cells. These cells formed lumens despite the presence of 2i/LIF (Extended Data Fig. 7g-j) . Although Otx2 knockout mES cells showed a delay in naive pluripotency exit, the lumenogenesis defect was rescued by overexpression of GFP-Podxl (Extended Data Fig. 7k-m) . Analysis of Oct4 and Otx2 data 18 from chromatin immunoprecipitation-sequencing experiments revealed the presence of an intronic enhancer approximately 3.5 Kb downstream of the Podxl transcription start site. In naive conditions this enhancer was bound by Oct4 and did not have activating H3K27ac marks. Naive pluripotency exit led to Otx2 binding and increased H3K27ac modifications (Extended Data Fig. 7n ). However, Podxl overexpression was insufficient to rescue lumen formation in naive cells; instead exogenous Podxl co-localized with Rab11 ( Fig. 4g and Extended Data Fig. 7o, p) . Analysis of the expression of genes involved in the fusion of Podxl-containing vesicles 25 in E4.5-E5.5 epiblasts 8 revealed that the tight junction protein cingulin (Cgn) was induced upon naive pluripotency exit. We confirmed this in embryos and mES cells (Fig. 4h and Extended Data Fig. 8a, b) . In Madin-Darby canine kidney (MDCK) cells, Cgn mediates lumenogenesis by tethering Rab11 vesicles through association with the Rab11-interacting protein Fip5 26 . Indeed, we found that Fip5 showed polarized localization and associated with Podxl upon 2i/LIF removal (Extended Data Fig. 8c ). 
letter reSeArCH
Depletion of Cgn led to a lumenogenesis defect and accumulation of Podxl in the cytoplasm (Fig. 4i, j) , without affecting naive pluripotency exit (Extended Data Fig. 8d, e) . Thus, in mES cells Cgn mediates the apical fusion of Podxl-containing Rab11 vesicles.
The human epiblast also transforms into an epithelium enclosing a lumen (the amniotic cavity) at implantation 2 . However, whether this occurs at the same time as a pluripotency change remains unknown. We found that at E6-7, epiblast cells (GATA6 − ) expressed the naive factor KLF17 27 and did not express PODXL, whereas 4 out of 9 human embryos cultured until E9-10 11,28 , had a PODXL-coated lumen (Fig. 5a, b) . Upon addition of inhibitors and growth factors (5i/LAF: MEK inhibitor, GSK3 inhibitor, RAF inhibitor, Src inhibitor, ROCK inhibitor, human LIF, activin A and bFGF2) that preserve naive pluripotency in hES cells 29 , embryos failed to form a lumen, displayed high levels of KLF17, NANOG and the naive marker CD130 30 , and showed a mild increase in apoptosis (Fig. 5b-e and Extended Data Fig. 9a-f) .
Finally, we determined the tissue-level characteristics of distinctive human pluripotent states in different naive cultures. hES cells overexpressing NANOG and KLF2 with 2i/hLIF have been shown to remain in a naive-like state 29, 31 . We found that presence of DOX upregulated naive markers and abolished lumenogenesis, whereas DOX removal or switching to primed conditions induced naive pluripotency exit and lumenogenesis (Extended Data Fig. 10a -e). In transgeneindependent naive conditions (RSet medium and 5i/LAF 29 ), we found that although NANOG and KLF2 were downregulated, naive markers were highly expressed and lumenogenesis was abolished without alterations in the initial polarization (Fig. 5f , g and Extended Data Fig. 10f-m) . Switching to primed conditions led to both rosette and lumen formation (Extended Data Fig. 10n, o) . Therefore, in human embryos and hES cells, a pluripotent transition is required for amniotic cavity formation (Fig. 5h) .
Here we show an evolutionary conserved mechanism that unifies transcriptional and architectural changes of the epiblast. Failure to exit from naive pluripotency leads to impaired cavity formation and this in turn could contribute to high rates of embryo loss at implantation. Slow-frozen human embryos (day 5-6) were thawed using Quinn's Advantage Thaw Kit (ART-8016, LifeGlobal Group), and vitrified human embryos (day 5-6) were thawed using Kitazato Thawing Solutions (VT802-0, Hunter Scientific) following the manufacturer's instructions. Embryos were cultured in human embryo culture media SAGE 1-Step (67010060A, LifeGlobal Group) for 24 h before zona pellucida removal with Acidic Tyrode's solution (T1788, Sigma-Aldrich). Embryos were washed in SAGE 1-Step medium and subsequently cultured using a pre-to post-implantation culture method, as previously described 11 . In brief, embryos were plated in IbiTreat μ -plates (IB-80826, Ibidi GmbH) in IVC1 (control) or IVC1 supplemented with 5i/LAF and cultured at 37 °C in 21% O 2 , 5% CO 2 . After 24 h of culture, half of the medium was replaced with fresh IVC1. After 48 h of culture, half of the medium was replaced with fresh IVC2. After 72 h of culture, embryos were fixed with 4% PFA (15710, Electron Microscopy Sciences). The exact composition of the medium was as follows. Embryos that attached to the plates and preserved the epiblast lineage were considered for statistical analyses. From a total of 87 embryos thawed, 8 were fixed at the blastocyst stage (Fig. 5a ). Out of these 8 embryos, 4 had epiblast cells as determined by immunofluorescence. The remaining 79 human embryos were cultured in the IVC system. Out of these 79 embryos, 34 survived the thawing procedure, attached to the plates and survived in the in vitro culture system. Out of these 34, the epiblast lineage was preserved in 20 embryos ( Fig. 5 and Extended Data Fig. 9 ). Mouse embryos. Mice were kept in the animal house in accordance with national and international guidelines. All experiments have been regulated by the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB). Experiments were approved by the Home Office. Animals were inspected daily and those that showed health concerns were culled by cervical dislocation.
Mouse embryos were recovered at embryonic days E4.5 (09:00) and E4.75 (16:00) from naturally mated F1 (C57BL/6 × CBA) or MF1 females by flushing the uterus with M2 medium. Embryos recovered at E5.0 (00:00) and E5.5 were manually dissected from the decidua. Females were used for natural matings at 3 ± 1 month of age.
For mES cell-embryo chimaera experiments, embryos were obtained from F1 females superovulated by injection of 7.5 IU of pregnant mares' serum gonadotropin (PMSG, Intervet), followed by injection of 7.5 IU of human chorionic gonadotropin (hCG, Intervet) and mating with F1 males. Chimeric embryos were transferred to F1 females mated with vasectomized CD1 males. Superovulated females were used at 6 ± 1 week of age.
To culture embryos through the pre-to post-implantation transition, mural trophectoderm of E4.5 mouse embryos was removed as previously described 9 . Embryos were subsequently plated in 8-well μ -Slides (80826, Ibidi) for 24 h in IVC1 medium. Epiblast dissection at peri-implantation stages. CAG-GFP-expressing mouse embryos 33 were recovered at E4.5, E4.75 and E5.0. The mural trophectoderm (E4.5 and E4.75 embryos) and the extraembryonic ectoderm (E5.0 embryos) were removed with a finely pulled glass pipette. Embryos were then treated for 15 min at 4 °C with Cell Dissociation Buffer (enzyme-free) (13150016, Thermo Fisher Scientific) followed by pipetting with a narrow glass pipette. This treatment removed most of the primitive endoderm, visceral endoderm and polar trophectoderm cells. If remaining GFP − cells were observed, these were separated with a finely pulled glass pipette. mES cell culture. mES cells were routinely cultured in gelatin-coated plates in N2B27 medium with 2i/LIF at 37 °C, 5% CO 2 , 21% O 2 . N2B27 medium comprised a 1:1 mix of DMEM F12 (21331-020, Thermo Fisher Scientific) and neurobasal A (10888-022, Thermo Fisher Scientific) supplemented with 1% v/v B27 (10889-038, Thermo Fisher Scientific), 0.5% v/v N2 (homemade), 100 μ M β -mercaptoethanol (31350-010, Thermo Fisher Scientific), penicillin-streptomycin (15140122, Thermo Fisher Scientific) and GlutaMAX (35050061, Thermo Fisher Scientific). N2 supplement contained DMEM F12 medium (21331-020, Thermo Fisher Scientific), 2.5 mg ml −1 insulin (I9287, Sigma-Aldrich), 10 mg ml −1 Apotransferrin (T1147, Sigma-Aldrich), 0.75% bovine albumin fraction V (15260037, Thermo Fisher Scientific), 20 μ g ml −1 progesterone (p8783, Sigma-Aldrich), 1.6 mg ml −1 putrescine dihydrochloride (P5780, Sigma-Aldrich) and 6 μ g ml
sodium selenite (S5261, Sigma-Aldrich). 2i/LIF (1 μ M MEK inhibitor PD0325901 (Stem Cell Institute), 3 μ M GSK3 inhibitor CHIR99021 (Stem Cell Institute) and 10 ng ml −1 LIF (Stem Cell Institute)) was added to N2B27 medium to preserve naive pluripotency. Exit from naive pluripotency was triggered by removal of 2i/LIF. Where indicated, mES cells were cultured for a minimum of four passages using different combinations of inhibitors (MEK inhibitor (MEKi)-LIF, GSK3 inhibitor (GSK3i)-LIF, MEKi-GSK3i (2i)). Cells were routinely tested for mycoplasma contamination by PCR.
As an alternative way to preserve naive pluripotency, mES cells were cultured on mitomycin C (M4287, Sigma-Aldrich)-treated mouse embryonic fibroblasts (MEFs) in Fc medium supplemented with 5 μ M Gö6983 (G1918, Sigma-Aldrich). Fc medium contained DMEM (41966, Thermo Fisher Scientific), 15% fetal bovine serum (Stem Cell Institute), penicillin-streptomycin (15140122, Thermo Fisher Scientific), GlutaMAX (35050061, Thermo Fisher Scientific), MEM non-essential amino acids (11140035, Thermo Fisher Scientific), sodium pyruvate (11360070, Thermo Fisher Scientific) and 100 μ M β -mercaptoethanol (31350-010, Thermo Fisher Scientific).
Cells were routinely passaged with trypsin-EDTA (25300054, Thermo Fisher Scientific). Fc medium was subsequently added to neutralize the trypsin and cells were centrifuged at 1,000 r.p.m. for 5 min.
The following mES cell lines were used: E14 wild-type mES cells (provided by A. Smith, Stem Cell Institute), 129 wild-type mES cells (provided by J. Hanna, Weizmann Institute of Science), Δ PE-Oct4-GFP mES cells 34 (provided by A. Surani, The Gurdon Institute), Rex1::GFPd2 mES cells 35 (provided by A. Smith, Stem Cell Institute), Nanog-YFP mES cells 36 , Dgcr8-knockout mES cells 14 (provided by J. Hanna, Weizmann Institute of Science), Otx2-knockout mES cells 18 , and KH2 DOX-inducible Nanog mES cells (provided by K. Hochedlinger, Harvard Stem Cell Institute). mES cell-embryo chimaeras. Chimaeras were generated by combining H2B-GFP-expressing mES cells with eight-cell stage mouse embryos. In brief, four-cell stage embryos were recovered by flushing the oviducts with M2 medium. Embryos were cultured in KSOM medium (MR-020P-5F, Millipore) until the eight-cell stage, at which point the zona pellucida was removed by brief treatment with Acidic Tyrode's solution (T1788, Sigma-Aldrich). H2B-GFP-expressing mES cells were cultured in a 3D Matrigel for 24 or 72 h. To obtain a single-cell suspension, the 3D cultures were treated with Cell Recovery Solution (354253, Corning) for 15 min at 4 °C. The Matrigel was broken into small pieces with a scrapper, the resulting suspension was centrifuged and the cell pellet was gently resuspended in trypsin-EDTA (25300054, Thermo Fisher Scientific). After trypsin inactivation, cells were plated in gelatin-coated plates. The resulting mES cell colonies were gently dissociated into small clumps and aggregated with the eight-cellstage embryos in M2 medium. The resulting chimaeras were cultured in KSOM medium until E3.5, when they were transferred into pseudo-pregnant females. Chimaeras were recovered at E6.5. mES cell derivation. For Nanog-YFP mES cell derivation, eight-cell stage mouse embryos were recovered from the oviducts of pregnant females and cultured in KSOM (MR-020P-5F, Millipore) in the presence of 2i. After 24 h, the medium was changed to N2B27 with 2i/LIF for 48 h. Hatched blastocysts were subsequently plated on mitomycin C-treated MEFs in Fc medium containing 2i/LIF. Two days later, blastocysts outgrowths were trypsinized and plated to obtain mES cell colonies. Positive colonies were identified by immunofluorescence and PCR using two different sets of primers: Nanog-YFP PCR1 FW1: AGCCTTGGAATGCTGCTCCGC; Nanog-YFP PCR1 RV1: CAATTAGAGCTATGCAGAGAA; Nanog-YFP PCR1 RV2: CCACCCCGG TGAACAGCTCC; Nanog-YFP PCR2 FW1: AGCCTTGGAATGCTGCTCCGC; Nanog-YFP PCR2 RV1: CTGGTCTGCAGAGCTAGTTC; Nanog-YFP PCR2 RV2: CCACCCCGGTGAACAGCTCC.
For derivation of mES cells from implantation cultures, 24 h after culture in IVC1 or IVC1 + 2i/LIF embryos were plated on mitomycin C-treated MEFs in Fc medium containing 2i/LIF. Two days later, the outgrowths were trypsinized and re-plated and the appearance of dome-shaped mES cell colonies was monitored. hES cell culture. All hES cell experiments were approved by the UK Stem Cell Bank Steering Committee and comply with the regulations of the UK Code of Practice for the Use of Human Stem Cell Lines. The WIBR3 Δ PE-OCT4-GFP DOX-inducible NANOG KLF2 hES cell line 29 (provided by R. Jaenisch, MIT) was routinely cultured on irradiated CF-1 MEFs (GSC-6101G, Amsbio) in N2B27 medium with 2i/hLIF and DOX at 37 °C, 5% CO 2 , 21% O 2 . N2B27 medium comprised a 1:1 mix of DMEM F12 (21331-020, Thermo Fisher Scientific) and Neurobasal A (10888-022, Thermo Fisher Scientific) supplemented with 2% v/v B27 (10889-038, Thermo Fisher Scientific), 1% v/v N2 (17502048, Thermo Fisher Scientific), 100 μ M β -mercaptoethanol (31350-010, Thermo Fisher Scientific), penicillin-streptomycin (15140122, Thermo Fisher Scientific), GlutaMAX (35050061, Thermo Fisher Scientific), MEM non-essential amino acids (11140035, Thermo Fisher Scientific), 50 μ g ml −1 BSA (A3311, Sigma-Aldrich) and 0.5% v/v KnockOut Serum Replacement (10828010, Thermo Fisher Scientific). To preserve naive pluripotency 2i/hLIF and DOX were added to the medium (1 μ M MEK inhibitor PD0325901 (Stem Cell Institute), 3 μ M GSK3 inhibitor CHIR99021 (Stem Cell Institute), 20 ng ml −1 recombinant human LIF (300-05, PeproTech) and 1 μ g ml −1 doxycycline hyclate (D9891, Sigma-Aldrich). Cells were routinely passaged once or twice per week by treatment with StemPro Accutase reagent (A1110501, Thermo Fisher Scientific) for 3 min, followed by addition of Fc medium and centrifugation for 3 min at 1,000 r.p.m. Cells were routinely tested for mycoplasma contamination by PCR.
To convert naive hES cells to primed conditions, two days after plating the medium was changed to DMEM F12 (21331-020, Thermo Fisher Scientific) supplemented with 15% FBS (10082139, Thermo Fisher Scientific), 5% KnockOut Serum Replacement (10828010, Thermo Fisher Scientific), GlutaMAX (35050061, Thermo Fisher Scientific), MEM non-essential amino acids (11140035, Thermo Fisher Scientific), penicillin-streptomycin (15140122, Thermo Fisher Scientific), 100 μ M β -mercaptoethanol (31350-010, Thermo Fisher Scientific) and 4 ng ml −1 bFGF2 (Stem Cell Insitute). Four to five days later, and when clear primed colonies were identified, cells were passaged using collagenase-dispase (000000010269638001, Sigma-Aldrich) for 15 min, followed by addition of Fc medium, centrifugation for 3 min at 1,000 r.p.m. and plating in the presence of 10 μ M ROCK inhibitor Y-27632 (72304, StemCell Technologies) for 24 h. Primed hES cells were switched to a MEF-independent culture by using Geltrex (A1569601, Thermo Fisher Scientific)-coated plates and mTESR1 medium (05850, StemCell Technologies). Primed hES cells cultured in mTESR1 were routinely passaged using StemPro Accutase reagent (A1110501, Thermo Fisher Scientific). During the first 24 h after passaging, 10 μ M ROCK inhibitor Y-27632 (72304, StemCell Technologies) was added to the medium. Naive WIBR3 Δ PE-OCT4-GFP DOX-inducible NANOG KLF2 hES cells were plated on CF-1 MEFs and two days after plating the medium was switched to transgene-independent naive hES cell medium. Two different formulations were used: 5i/LAF 29 consisted of N2B27 medium supplemented with 20 ng ml −1 recombinant human LIF (300-05, PeproTech), 20 ng ml Transgene-independent hES cells were routinely cultured on CF-1 MEFs (GSC-6101G, Amsbio) and passaged using StemPro Accutase reagent (A1110501, Thermo Fisher Scientific). mES cell spheroid formation. To induce polarization and lumenogenesis of mES cells, we used Matrigel, because it can mimic the basement membrane in vitro that surrounds the epiblast at implantation in vivo 1 . Two different protocols were used 37 .
Embedded. Pellets containing 20,000 mES cells were resuspended in 20 μ l of icecold growth factor-reduced Matrigel (356230, BD Biosciences). The solution was placed as a drop in a well of a μ -Slide 8-well ibiTreat (IB-80826, Ibidi) dish and incubated for 5 min at 37 °C to allow the Matrigel to solidify. Next, 300 μ l of medium (N2B27 or Fc depending on the experiment) was added to the well. 3D on top. A well of a μ -Slide 8-well ibiTreat (IB-80826, Ibidi) dish was covered with 35 μ l of ice-cold growth factor-reduced Matrigel (356230, BD Biosciences) and incubated for 5 min at 37 °C to allow the Matrigel to solidify. In the meantime, 20,000 mES cells were resuspended in N2B27 and the cell suspension was carefully plated on the Matrigel-coated well. When approximately 80% of the cells had attached to the Matrigel (5-10 min after plating), the medium was removed and replaced with N2B27 containing 5% Matrigel. Where indicated mES cells were treated with 50 μ g ml −1 of protamine sulfate (1101230005, Merck Millipore).
hES cell spheroid formation. hES cells were induced to polarize and form lumens using the 3D on top protocol as previously described 11, 32 . In brief, a single-cell suspension of hES cells was plated on Matrigel-coated μ -Slide 8-well ibiTreat (IB-80826, Ibidi) dishes as described in 'mES cell spheroid formation' . Upon attachment to the Matrigel-coated surface, the medium was replaced with hES cell medium (mTESR or naive hES cell medium depending on the experiment) containing 5% Matrigel. To avoid single-cell-induced primed hES cell death, 10 μ M ROCK inhibitor Y-27632 (72304, StemCell Technologies) was added to the medium for 24 h. To monitor the dynamics of naive pluripotency exit and morphogenesis, naive hES cells were plated in 3D Matrigel in mTESR medium. siRNA treatments. mES cells were transfected with Lipofectamine RNAiMAX transfection reagent (13778030, Thermo Fisher Scientific) using a reverse transfection protocol. In brief, 100,000 cells were plated on gelatin-coated 12-well plates together with the Lipofectamine RNAiMAX-siRNA mix. In total, 0.5 μ l of a 20-μ M siRNA solution was used per well. AllStars negative control siRNAs (1027280, Qiagen) were used as control.
For downregulation of Podxl expression an equimolar mix of the following siRNAs (Qiagen) was used: SI01383123: AAGAAUGUAAAUGUCUAUUUA; SI01383130: CUGGAAUUUAUUGAGAGAUUA; SI01383137: CCCAAUU UCCAUCUCCUAUAA.
For downregulation of Cgn expression an equimolar mix of the following stealth siRNAs (Thermo Fisher Scientific) was used: CgnMSS230393: CCCUCAUC CAUUGCAUCACUGCUUA; CgnMSS230394: GAAGACAGUUCUGCAG UCCACCAAU; CgnMSS230395: GGCUUGCCUUUAUGAGUCCUAGUAA.
For downregulation of Nanog expression an equimolar mix of the following siRNAs (Qiagen) was used: SI01323357: AGCCTTGGAATTATTCCTGAA; SI04460869: TGCCAGTGATTTGGAGGTGAA; SI04460883: CAGGTTT CAGAAGCAGAAGTA.
For downregulation of Oct4 expression the following stealth siRNA (Thermo Fisher Scientific) was used: Pou5f1MSS237605: ACCUUCUCCAACUU CACGGCAUUGG. Cloning. Cloning procedures were carried out using Gateway technology (Thermo Fisher Scientific). In brief, the fragment of interest was amplified by PCR to introduce attB sites. This was cloned into a pDONR221 vector (gift of J. Silva, Stem Cell Institute) using the BP clonase II (11789020, Thermo Fisher Scientific). The fragment of interest was further subcloned into a pHygro or pBlasticidin vector containing a hygromycin B-or blasticidin-resistance cassette, respectively (gift of J. Silva, Stem Cell Institute) for expression in mammalian cells. The recombination reaction was carried out using the LR Clonase II (11791100, Thermo Fisher Scientific).
GFP-Rab11a S25N (dominant negative): a Rab11a
S25N
-pEGFP plasmid was used as a template for cloning (provided by J. Clarke, King's College London). The fragment corresponding to GFP-Rab11a S25N was amplified by PCR using the following primers: Rab11a F W: G GG GA CA AG TT TG TA CA AA AA AG CA GG CT TC AC C A TG GTGAGCAAGGGCGAGGAG; R ab 11 a RV: G GG GA CC AC TT TG TA C A AG AA AG CT GG GT CT TA GA TGTTCTGACAGCACTGC.
GFP-Podxl: a GFP-Podxl-pEGFP plasmid 22 was used as a template for cloning (provided by A. Echard, Institut Pasteur). The fragment corresponding to CD8 tag-VSV-g tag-EGFP-Rhodopsin-rabbit Podxl was amplified by P CR using the following primers: Podxl FW: G GG GA CA AG TT TG TA CA AA AA AG CA GG CT TC A C CA TG GCCTTACCAGTGACCGC; Podxl RV: G GG GA CC AC TT TG TA CA AG A A AG CT GG GT CT TA GA GGTGCGTGTCTTCCTC.
GFP-Cd34: Mouse Cd34 was amplified from cDNA using the following primers: Cd34 FW: ACCACGGAGACTTCTACACAAGG; Cd34 RV: TCAC AGTTCTGTGTCAGCCAC.
Using the GFP-Podxl-pEGFP plasmid as a template, the N-terminal region corresponding to CD8-VSV-G-GFP-rhodopsin was amplified by PCR using the following primers: GFP FW: ATGGCCTTACCAGTGACCGC; GFP RV: GAA TTCCGTCGCATTGGAGAA.
The two fragments were joined by overlap PCR and attB sites were added for cloning into the pBlastidicin vector.
H2B-GFP: an H2B-GFP-expressing plasmid was used as template for cloning (provided by M. Perez-Moreno, CNIO). The fragment corresponding to H2B-GFP was amplified by PCR using the following primers: H2B-GFP FW: GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGCCAGAGCCAG CGAAGT; H2B-GFP RV: G GG GA CC AC TT TG TA CA AG AA AG CT GG GT CT T A CT TG TACAGCTCGTCCATGC.
To generate a wild-type GFP-Rab11a construct we performed site-directed mutagenesis using the GFP-Rab11a S25N -pEGFP plasmid as a template. A fourprimer PCR strategy was designed to correct the mutated site. The following primers w er e used: Rab11a FW (external): G GG GA CA AG TT TG TA CA AA AA AG CA G G CT TC AC CA TG GTGAGCAAGGGCGAGGAG; Rab11a RV ( ex te rn al): G GG G A CC AC TT TG TA CA AG AA AG CT GG GT CT TA GA TGTTCTGACAGCACTGC; letter reSeArCH Rab11a wild type F W (internal): C TG GT GT TG GA AA GT CT AA TC TC TT G T CT CG AT TT AC TC GA AATGAGTTTAATCTCGAAAG; Rab11a wild type RV ( in te rn al): G AG ACAAGAGATTAGACTTTCCAACACCAGAATCTCCAATA AGGACAACTTTG.
The two fragments obtained were joined by overlap PCR. CRISPR-Cas9. Genome editing was performed using the CRISPR-Cas9 system as previously described 38 . Guide RNAs (gRNAs) were designed using the MIT CRISPR Design Tool (http://crispr.mit.edu/). A two-gRNA strategy was designed in order to remove the initiation ATG. The following gRNAs were used: gRNA1:CGAACTCC GGAGTCGCGATC; gRNA2: CTGCAAGCGGTCCGACCACG.
The gRNA templates were assembled and ligated into the PX459 vector. The following primers were used: gRNA1 FW: CACCGCGAACTCCGGAGTCGCGATC gRNA1 RV: AAACGATCGCGACTCCGGAGTTCGC; gRNA2 FW: CACCGCT GCAAGCGGTCCGACCACG; gRNA2 RV: AAACCGTGGTCGGACCGC TTGCAGC.
The two gRNA-expressing constructs were co-transfected into E14 mES cells. After 24 h of transfection, 2 μ g ml −1 of puromycin was added to the medium for 48 h to select for transiently transfected cells. Single cells were subsequently plated on 96-well plates with mitomycin C (M4287, Sigma-Aldrich)-treated MEFs in Fc 2i/LIF medium. Efficient gene editing was assayed by PCR using the following primers: Podxl Δ FW: ACACCTTCGCTCGTCGCTGC; Podxl Δ RV: GACTAGGAATAAATCCACGATCTGGCC. This generated a 485-bp wild-type band and a 200-bp knockout band.
Three knockout clones were selected for further analyses by RT-PCR (data not shown) and immunofluorescence. mES cell transfection. mES cells were transfected using Lipofectamine 3000 (L3000001, Thermo Fisher Scientific) following the manufacturer's instructions. In brief, the day before transfection 50,000 cells were plated on 24-well gelatin-coated plates in N2B27 2i/LIF medium without antibiotics. Table 2) at 4 °C overnight, followed by incubation with fluorescently conjugated Alexa Fluor secondary antibodies (Thermo Fisher Scientific) for 2 h at room temperature (Supplementary Table 2 ). Both primary and secondary antibodies were diluted in 1% BSA, 0.1% Tween-PBS.
Images were acquired on an inverted SP5 confocal microscope (Leica Microsystems) with a Leica HC PL APO 1.4 NA 63 × oil objective or on an inverted SP8 confocal microscope (Leica Microsystems) with a Leica HC PL APO CS2 1.4 NA 63 × oil objective or a Leica Fluotar VISIR 0.95 NA 25 × water objective. Time-lapse microscopy. Time-lapse images of mES cells were acquired on an inverted SP5 confocal microscope (Leica Microsystems) with a Leica HC PL FLUOTAR 0.5 NA 20.0 × dry objective. Cells were imaged in a humidified chamber with 21% O 2 and 5% CO 2 . Images were taken at intervals of 30 min with a z step of 4 μ m. Fixation and staining for serial block face imaging. Samples were fixed by immersion with 2% formaldehyde (made from PFA) and 2% vacuum-distilled glutaraldehyde, containing 2 mmol l −1 CaCl 2 , in 0.05 M sodium cacodylate buffer at 4 °C and pH 7.4 for 8 h at 4 °C. Samples were rinsed five times for 3 min in cold cacodylate buffer containing 2 mM CaCl 2 . After buffer washes, samples were incubated in 1% osmium ferricyanide for 18 h at 4 °C and rinsed five times in distilled-deionized water (DIW). This was followed by a 30-min incubation in 1% thiocarbohydrazide at room temperature and five more rinses in DIW. Samples were then incubated in 1% uranyl acetate in 0.05 maleate buffer pH 5.5 at 4 °C for 48 h. The samples were then rinsed five times for 3 min with DIW at room temperature and dehydrated by incubating twice with 50%, 70%, 90% and 100% ethanol, dry ethanol, dry acetone and dry acetonitrile. The dehydrated samples were infiltrated with Quetol 651 epoxy resin over a period of five days. The resin was cured for 48 h at 65 °C. Thin sections were prepared with a Leica Ultracut S mounted on 200-mesh copper grids and viewed with a Tecnia G2 operated at 200 kV. Image analysis. All microscopy data were analysed using Fiji software 39 (http:// fiji.sc). For 3D reconstructions, images were cropped and filtered in Fiji and the rendering was done using Chimera (v.1.8.1) (https://www.cgl.ucsf.edu/chimera/). For all quantifications, laser power and detector gain were maintained constant to quantitatively compare different experimental conditions within a single experiment. Quantification of nuclear fluorescence intensity in ES cells. DAPI images were binarized and a mask was created to segment the nuclei in 2D. These were saved as regions of interest (ROIs), which were used to delineate nuclei in the channel of interest, and nuclear fluorescence intensity was measured within each ROI. For every ES cell spheroid, a unique averaged fluorescence intensity value was generated. Error bars represent the variability (s.e.m.) across different spheroids from different independent experiments. To compare fluorescence intensity values across different experiments, raw fluorescence intensity values were normalized to the average fluorescence intensity of the corresponding control condition. Using this approach, mES cells were considered to be negative for Oct4 expression (in the Oct4 siRNA group) or negative for Nanog expression (in the Nanog siRNA group) when the average fluorescence of the spheroid was below the 25% percentile of the corresponding control group. Quantification of Podxl and Cgn. to determine whether a spheroid was negative for Podxl expression (in the Podxl siRNA group) or negative for Cgn expression (in the Cgn siRNA group), the Podxl or Cgn channels in the control group were used to set a threshold value of intensity. This threshold was applied to the experimental group and the images were binarized. mES cell spheroids that did not show any signal based on the threshold value of intensity were considered to be negative.
Quantification of nuclear fluorescence intensity in embryos.
A representative z plane was chosen for each embryo and the fluorescence intensity of epiblast pluripotency genes was measured using the DAPI channel to segment the nuclei as mentioned above. To account for changes in fluorescence in the z axis, the fluorescence intensity of the gene of interest in the epiblast was normalized to the fluorescence intensity of DAPI in the epiblast. Error bars represent the variability (s.e.m.) across different embryos.
Quantification of fluorescence intensity in time-lapse experiments.
To quantify the dynamics of naive pluripotency gene expression, the bright field channel was used to create a mask, which was applied to the channel of interest as mentioned above. To analyse the position of centrosomes, the nucleus-nucleus axis and the nucleus-centrosome axis were determined. The angle between both vectors was calculated and the x-y positions were normalized to the internuclear distance. Analysis of lumen and rosette formation. To quantitatively determine whether rosettes and lumens form in embryos and ES cell spheroids, we immunostained components of the Par polarity complex (either atypical protein kinase C (aPKC)-Par6 and/or Podxl), as these proteins are known to localize to the lumen in 3D in vitro cultures 20 and are used as bona fide luminal markers in different model systems 40, 41 . Phalloidin staining was used to reveal cell shapes. Lumens and rosettes displayed a polarized organization, whereas disorganized structures did not show a polarized localization of Par proteins and/or Podxl. In addition, the fluorescence intensity profile was plotted from a line drawn through the location of interest (rosettes or lumens). One peak of fluorescence intensity corresponds to a rosette (a closed spot of fluorescence), whereas two peaks depict a lumen (two walls and a central depression) (Figs 1a, 5d and Extended Data Fig. 2b are shown as examples) .
In Extended Data Fig. 9a , the F-actin channel was separated from the Nanog channel by applying a subtract function in Fiji. RNA extraction and RT-PCR. For RNA extraction of mES cells cultured in Matrigel (3D on top protocol), the Matrigel was first removed by treatment with Cell Recovery Solution (354253, Corning) for 15 min at 4 °C. To facilitate the depolimerization, the Matrigel was manually broken into small pieces. Cells were subsequently centrifuged and pellets were washed once with PBS.
RNA was extracted using TRIzol reagent (15596010, Thermo Fisher Scientific) following the manufacturer's instructions. Subsequently, 1 μ g of RNA was used to perform a reverse transcriptase reaction in the presence of random primers (C1181, Promega), dNTPs (N0447S, New England BioLabs), RNase inhibitor (M0314L, New England BioLabs) and M-MuLV reverse transcriptase (M0253L, New England BioLabs). RT-PCR reactions were carried out using Power SYBR Green PCR Master Mix (4368708, ThermoFisher Scientific) on a
Step One Plus Real-Time PCR machine (Applied Biosystems). The following program was used: 10 min 95 °C followed by 40 cycles of 15 s 95 °C (denaturing) and 1 min 60 °C (annealing and extension). The primers used are listed in Supplementary Table 3 .
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Mouse gene expression data were normalized to Gapdh; human gene expression data were normalized to HPRT1. Error bars represent variability (s.e.m.) across multiple independent experiments. Library preparation, RNA sequencing and mapping of reads. The SMARTSeq2 protocol 42 was used to amplify mRNA with the addition of ERCC spike-in control (1 μ l of 1:1,000,000 dilution of mix 1 (4456740, Ambion) per sample).
Nextera XT (Illumina) was used to generate multiplex sequencing libraries from amplified cDNA. Libraries were sequenced on a HiSeq 2500 running in rapid mode. The paired-end reads were then mapped to both the M. musculus genome (Ensembl v.38.77) and ERCC sequences using the default settings in GSNAP (v.2014-10-07). Htseq count 43 (v.0.6.1p1 with default options) was used to count the number of reads mapped to each gene. All samples were analysed in a single experiment to avoid batch effects. Sample quality assessment. Three metrics were used to assess data quality: the fraction of reads that were mapped, the number of genes that had more than 10 reads per million and the fraction of reads that were mapped to mitochondrial genes. Extended Data Figure 1b -e displays these metrics, with each being shown as a function of the total read number per sample. A principal component analysis (PCA) was run and outliers were defined as performing worse than average for all three metrics (Extended Data Fig. 1f ). These analyses uncovered one clear outlier (sample name 'E4.5_Sample1' , highlighted in grey), which was then excluded from all further downstream analyses.
We also controlled for possible contamination with cells from the primitive endoderm. We verified that the E5.0 samples did not show any expression of primitive endoderm markers, such as Gata6, Gata4, Sox17, Sox7 and Pdgfra. As for samples from E4.5 and E4.75 embryos, they all cluster with the epiblast samples previously published in ref. 8 (see Extended Data Fig. 1g ), except for one sample (E4.5_Sample3), which was found in the primitive endoderm cluster and was therefore excluded from further analysis (see 'PCA and hierarchical clustering' for details on the clustering algorithm).
The samples that passed the quality check were normalized for sequencing depth using size factors 44 calculated on endogenous genes. PCA and hierarchical clustering. The PCA plots shown in Fig. 1b and Extended Data Fig. 1f , h were generated using the log 10 -transformed read counts (by summing 1 to avoid infinities) of the combination of the 5,000 most highly expressed genes in each sample.
The hierarchical clustering shown in Fig. 1c and Extended Data Fig. 1g was based on the dissimilarity matrix defined as (1 − ρ) / 2, where ρ is the Spearman correlation coefficient between pairs of samples or genes. Once the dissimilarity matrix was calculated, the hierarchical tree was generated with the R function 'hclust' with the 'average' agglomeration method. Differential expression analysis. The Bioconductor package DESeq2 45 was used to find differentially expressed genes between E5.0 samples and E4.5-E4.75 samples at a 0.1 false discovery rate. Before running DESeq2, genes with an average expression level of less than 1 normalized read counts across all samples were excluded. Comparing our dataset to data in ref. 8 . In Extended Data Fig. 1h , before selecting the genes for the PCA, we pooled our data with the epiblast samples previously published in ref. 8 (FPKM normalized read-counts available from ref. 8 ) and performed a quantile normalization.
The log fold changes plotted in Extended Data Fig. 1i were computed after adding a pseudo-count of 0.1. The genes used for the clustering in Extended Data Fig. 1g are those differentially expressed between epiblast and primitive endoderm at E4.5 as reported in ref. 8 .
Statistical analyses. Statistical analyses were performed using GraphPad Prism (excluding the analysis of the sequencing data). Embryos were randomly allocated to control and experimental groups. Sample size was determined based on previous experimental experience. Investigators were not blinded to group allocation. Qualitative data are presented as a contingency table and were analysed with a χ 2 test. Quantitative data are presented as mean ± s.e.m. and were analysed for normality using a D' Agostino-Pearson omnibus normality test. Data with a Gaussian distribution were analysed using a two-tailed unpaired Student's t-test (two groups) or ANOVA (multiple groups) with a Tukey's multiple comparison test. Significant differences in the variance were taken into account using a Welch's correction. Data that did not have a Gaussian distribution were analysed using a Mann-Whitney U-test (two groups) or Kruskal-Wallis test (multiple groups) with a Dunn's multiple comparison test. For all quantifications a minimum of two independent experiments were performed. Sequencing data were analysed with standard programs and packages. Code availability. Code used for this study is available from the corresponding author upon reasonable request. Data availability. RNA sequencing data are available at Array Express (https:// www.ebi.ac.uk/arrayexpress/) under accession number E-MTAB-5147. The immunofluorescence and time-lapse data that support the findings of this study are available from the corresponding author upon reasonable request. Source Data for RT-PCR experiments and quantifications of the immunofluorescence data are provided with the paper. letter reSeArCH Extended Data Figure 1 | Epiblast gene expression patterns at peri-implantation stages. a, CAG-GFP + embryos recovered at periimplantation stages, before and after dissection of the epiblast. n = 4 E4.5, 4 E4.75 and 4 E5.0 embryos. b-e, For all the collected samples we computed the total number of reads (b), the fraction of reads mapped to endogenous genes (c), the number of genes with more than 10 reads per million (RPM) (d) and the fraction of reads mapped to mitochondrial genes (e). f, A PCA of the metrics shown in b-e. The sample coloured in grey (E4.5_S1) is characterized by a very low fraction of mapped reads and number of genes detected and was therefore removed from all downstream analysis. g, Hierarchical clustering of the E4.5-E4.75 samples that passed the quality check (black) and samples from the epiblast (red) and primitive endoderm (blue) at E4.5 from the dataset of ref. 8 . One sample (E4.5_S3, grey) clusters with the primitive endoderm, whereas all others cluster with the epiblast. E4.5_S3 was therefore excluded from further analysis. h, PCA of our samples and samples from ref. 8 Time after plating (h) Fgf5 relative mRNA levels 
E4.5 E4.75 E5.. i, log fold change in pluripotency marker genes between E5.0 and E4.5-E4.75 samples from our dataset (x axis) and log fold change between E5.5 and E4.5 epiblast samples from ref. 8 (y axis). Squares, circles and triangles mark genes differentially expressed
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